2-AMINO-4,4,4-TRIFLUORO-3-PHENYLBUTANOIC ACID, 97.0%, 250mg

(S)-2-((S)-2-Amino-3-phenylpropanamido)-3-(4-hydroxyphenyl)propanoic acid, 95.0%, 1g

(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, 98%, 50mg

4'-Fluoroacetophenone>98.0%(GC)25g

7-Bromo-2-methylquinoline, 95.0%, 1g

3-(difluoromethyl)-1-methyl-1H-pyrazol-5-ol, 97.0%, 10g

(4-{[5-(Trifluoromethyl)pyridin-2-yl]oxy}phenyl)methanol, 97.0%, 1g

(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)methanol, 95.0%, 100mg

2-(4-Fluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

2,3-Dichlorobenzyl Chloride>98.0%(GC)25g

n-[(2,4-dimethoxyphenyl)methyl]pyrimidin-2-amine, 98%, 100mg

Centrifuge filter unit Ultrafree Ultrafree-MC, PVDF membrane, sample volume up to 0.5 ml, 0,65 µm, Sterile, 50 Piece(s)

H-Tyr(3-Cl)-OH>95.0%(HPLC)(T)1g